Efficacy and Safety of Small-Particle Cross-Linked Hyaluronic Acid Intradermal Injection for Improving Facial Skin Quality: A Retrospective Real-World Study
International Open Medical Journal (IOMJ) · 09.11.2026 · 2 · 170-183
DOI: 10.65364/iomj.2026.08 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Open Medical Journal (IOMJ), online erschienen am 09.11.2026. Verfasst von Chungyung Keung und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the efficacy and safety of intradermal Small-particle cross-linked hyaluronic acid (SPCLHA) injection for improving facial skin texture and appearance in a real-world study in a Chinese population.
Methods
The SPCLHA injection has been used to improve skin texture on the face, neck, chest, and dorsal hands. However, real-world efficacy and safety evidence for the facial injection of SPCLHA for skin improvement is limited in China. We retrospectively reviewed electronic medical records to collect real-world data from participants who received at least two facial intradermal injections of SPCLHA at a Chinese clinic. The skin quality of participants was evaluated at pre-injection and after each injection using the Global Aesthetic Improvement Scale (GAIS) and the Global Photoaging Score (GPS). Safety was measured by monitoring the occurrence of adverse events. We also evaluated participant’s satisfaction through surveys.
Results
The study included 39 female participants with an average age of 38.7 years, all of whom received at least three injections. Data for the first two injections were available for all participants, and 21 participants had data for the third injection. We observed a significant increase in the proportion of participants achieving the highest GAIS score, with 2.6% after the first injection, 28.2% after the second injection, and 42.9% after the third injection. Trends in the GPS scores also showed a decrease in the severity of photodamaged skin. The distribution of GPS scores was significantly different from the second injection to the pre-injection (p = 0.003), indicating fewer participants had high GPS scores after the injections. No adverse events were reported during the study period, and 94.9% of participants were satisfied with the effects.
Conclusion
This real-world study showed that the intradermal injection of SPCLHA was effective in improving facial skin texture and appearance, and was found to be safe for use in the real-world Chinese population. Key Words: skin barrier, skin physiology/structure, formulation/stability, small-particle cross-linked hyaluronic acid, skin quality
Zitieren
APA
Keung, C., Li, Q., Mao, J., Jin, S., Lin, Y., & Li, Q. (2026). Efficacy and Safety of Small-Particle Cross-Linked Hyaluronic Acid Intradermal Injection for Improving Facial Skin Quality: A Retrospective Real-World Study. International Open Medical Journal (IOMJ), 2, 170-183. https://doi.org/10.65364/iomj.2026.08
Vancouver
Keung C, Li Q, Mao J, Jin S, Lin Y, Li Q. Efficacy and Safety of Small-Particle Cross-Linked Hyaluronic Acid Intradermal Injection for Improving Facial Skin Quality: A Retrospective Real-World Study. International Open Medical Journal (IOMJ). 2026;2:170-183. doi:10.65364/iomj.2026.08
BibTeX
@article{Keung2026,
author = {Keung, Chungyung and Li, Qinyang and Mao, Jianxun and Jin, Shunnv and Lin, Yuanyuan and Li, Qing},
title = {Efficacy and Safety of Small-Particle Cross-Linked Hyaluronic Acid Intradermal Injection for Improving Facial Skin Quality: A Retrospective Real-World Study},
journal = {International Open Medical Journal (IOMJ)},
year = {2026},
volume = {2},
pages = {170--183},
doi = {10.65364/iomj.2026.08}
}
EUVIMED